Introduction {#s0005}
============

Several recent investigations have shown limitations of fMRI reliability with the current standard field strengths (1.5--3 T, e.g. [@bb0005]). This may be problematic for conclusions drawn from neuroscientific studies or patient examinations. Limitations are due to methodological challenges which affect the functional signal change and contrast to noise ratio. Low contrast to noise is a particular problem for cognitive tasks. For example, task specific signal modulations with sophisticated language tasks may be small and signal variability typically rather large, generating a challenging situation for cognitive fMRI research. Further, contrast to noise quality is particularly critical within a clinical context. Here the challenge is to generate reliable data in single subjects without being able to average over a group, and the fMRI methods need to work with atypical morphology and functionality.

All these issues require improvement of the functional signal strength. One of the most promising approaches is to perform fMRI at ultra-high field strength (7 T) to take advantage of the considerable increase of the signal to noise ratio (SNR). In the recent history of changes in MR technology, the demonstration of increased SNR and increased BOLD sensitivity drove the historic change from 1.5 T to 3 T as the current quasi-standard technology ([@bb0010]). Correspondingly, great hopes for an improved fMRI reliability rest on 7 T ultra high-field (UHF) systems, with about 70 installations currently worldwide. However, detailed theoretical predictions regarding UHF benefits are difficult, since several factors could offset possible advances (e.g. increased artifact level, scaling of physiological noise with field strength, dependence of effects on the voxel size). Therefore experimental investigations of how much and under which task conditions SNR and contrast-to-noise (CNR) improvements occur are clearly needed, but only limited data currently exist.

A few previous fMRI studies compared 7 T with lower field strengths on healthy brains using robust sensory or motor stimulations (e.g. [@bb0015; @bb0070; @bb0085; @bb0130; @bb0140; @bb0075]). One previous study investigated UHF benefits in patients, also applying a motor task (tumor patients, [@bb0040]). Concerning cognitive fMRI research, only 2 3 T--7 T studies in healthy subjects exist which investigated focal activation changes (hippocampus: [@bb0125], amygdala: [@bb0120]). There have been no studies on the benefit of UHF for the study of cognitive networks. The same holds true for cognition studies in pathological brains. Since the most prominent and also clinically most important cognitive human function is language processing, we performed the current study investigating possible functional benefits of UHF MR for investigation of the language network. The most difficult conditions for UHF are pathological brains, which represent the worst case scenario for signal variability and methodological challenges. If an increased sensitivity for cognitive networks can be demonstrated here, UHF benefits are even more likely for healthy brains. For that reason we acquired data of tumor patients and -- as in our previous study with a motor task --- functional signal was assessed in non-transformed (non-normalized) individual brains. This is important to be able to extend conclusions about possible cognitive network benefits to the clinical environment where UHF benefits are required for individuals rather than groups.

Materials and methods {#s0010}
=====================

Patients {#s0025}
--------

The study was approved by the local ethics committee of the Medical University of Vienna. All patients participated with written informed consent. To allow a realistic evaluation of UHF benefits for typical clinical populations all patients who were referred for presurgical language localization in a given period were considered for inclusion in this study. The requests for presurgical planning were not influenced by the authors and therefore included 3 patients with only right hemispheric pathology (see [Table 1](#t0005){ref-type="table"} for demographic and clinical details). Other than the receipt of an external request for language localization, the only inclusion criterion was the ability to perform the task and tolerate two fMRI measurement sessions. Exclusion criteria were clinical or MR contraindications. At the time of measurement, all twenty six right-handed patients (10 females, mean age 26.8 years old and 16 males, mean age 35.71 years old; age range 8--69 years of age) were in good general health and could perform the task well. Clinical fMRI reports were generated with a different analysis from that presented in this study, and are not reported here.

Task {#s0030}
----

The language task was an overt speech paradigm ([@bb0050; @bb0055]) which reproduces typical everyday communication demands. The basic experimental setup comprised 20 pseudorandomized block-designed fMRI runs of a syntactic (10 runs) and a semantic task (10 runs). Each run consisted of 4 control and 3 activation periods with duration of 20 s each. During an activation period, two 5-word sentences were automatically presented word by word. The final word consisted of 2 alternative verbs that were either syntactically or semantically correct or incorrect (cf. [@bb0055]). One sentence was displayed for 10 s. The instruction was to read overtly every word and to repeat the correct final sentence. All subjects were trained to speak softly and to minimize movements of head and facial muscles. Depending on the patient\'s tolerance and performance, between 9 and 20 complete runs were acquired.

Image acquisition {#s0035}
-----------------

All subjects were examined with both a Siemens 3 T whole body MAGNETOM TIM TRIO scanner and a Siemens MAGNETOM 7 T whole body scanner (Siemens Healthcare, Erlangen, Germany). A 32 channel head coil was used at 3 T (Siemens Healthcare). Due to ongoing hardware upgrades, a few patients scanned at 7 T were measured with an 8 or 24 channel head coil but most of the measurements were done with a 32 channel head coil (Nova Medical, Wilmington Massachusetts, USA). Measurements at 3 T and 7 T were carried out with an average separation of 7.21 (SD: 10.56) days and system order was randomized. To minimize head motion artifacts, individually constructed plaster cast helmets ([@bb0045]) were used on both systems. On both systems functional data were acquired with a 2D single shot gradient-echo (GE) EPI sequence, with slices aligned parallel to the AC--PC plane and whole brain coverage. As in [@bb0040], efforts were made to avoid confounding effects not primarily related to static magnetic field strength and -- with the principal exception of echo time (TE) -- keep measurement parameters consistent between systems where possible. System specific sequence adaptations were minimized (e.g. according to specific absorption rate (SAR) guidelines, whole brain coverage requirements, different TE values).

### Common sequence parameters {#s0040}

On both systems FOV 230 mm, matrix size of 128 × 128 × 34, 56 repetitions, slice thickness 3 mm and TR 2500 ms were used. We also applied parallel imaging with GRAPPA-iPAT factor 2, fat suppression by a chemical shift selective saturation pulse prior to every slice and 10 s of dummy scans.

### Differing sequence parameters {#s0045}

3 T: TE 28 ms, bandwidth 2220 Hz, flip angle 90°, full Fourier encoding, no gap between slices. Vendor provided fat saturation module with a preset flip angle of 110°.

7 T: TE 22 ms, bandwidth 1445 Hz, flip angle 80°, 6/8 partial Fourier factor (omitting the first 25% of k-space phase-encoding lines), 10% gap between slices. The effective echo time at 7 T was optimized via assessment of T2\* for this resolution. Flip angles of the vendor-provided fat saturation module was reduced to 90° due to specific absorption rate (SAR) limitations.

### Field maps {#s0050}

To get investigate area-specific image distortions in a subsample of patients, B0 field maps were acquired for six patients at 7 T (for 5 patients with the 24 channel coil, for one patient with the 8 channel coil). With the 24 channel coil field maps were acquired with a triple-echo (TE = 4.6, 9.3, 14.1 ms) gradient-echo (GE) sequence and with the 8 channels with a dual-echo (TE = 10.0, 13.9 ms) GE sequence. Other field map parameters were consistent for all patients: TR = 1010 ms, FA = 30° and fat saturation, 53 AC--PC axial slices of 2 mm thickness with 0.3 mm gap, 128 × 128 matrix, FOV 230 mm, pixel bandwidth = 260 Hz and GRAPPA factor 2 in the same geometry as the GE-EPIs.

### Structural image {#s0055}

High-resolution T1-weighted MR images were acquired using a 3D MPRAGE sequence with a matrix size of 320 × 320 × 224, with 0.7 mm isotropic resolution, flip angle of 9° and GRAPPA acceleration factor 2; acquisition time 7 min and 57 s.

fMRI data analysis {#s0060}
------------------

With every patient the same number of artifact free 3 T and 7 T runs was entered into the analysis. All superfluous runs were excluded (by acquisition order, to avoid bias). Functional data were pre-processed and statistical analysis was performed using SPM8 (Wellcome Department of Imaging Neuroscience, London, UK; <http://www.fil.ion.ucl.ac.uk/spm>). To reduce residual small-scale motion, all runs were registered to the first scan using default settings, except that the factors "Quality: 0.95" and "Separation: 2" were used to improve correction quality. No slice timing correction or spatial normalization was carried out. Functional images were smoothed with a 4 × 4 × 6 mm full width at half maximum (FWHM) Gaussian kernel. First level statistical analysis was performed with a fixed effects analysis (SPM default settings, no additional temporal filtering or averaging) with inclusion of motion parameters in the design matrix as nuisance variables. BOLD responses were modeled by a fixed response boxcar function convolved with the canonical hemodynamic response. Activation was established for each patient via voxel-wise t-tests to generate individual SPM t-maps.

### Definition of the particular target areas (Broca\'s and Wernicke\'s areas) {#s0065}

To allow inferences about benefits for individual subjects and minimize postprocessing related confounds ([@bb0035]) all functional analyses were performed on non-transformed (non-normalized) individual data ([Fig. 1](#f0005){ref-type="fig"}). The analysis was focused on left hemispheric essential areas of the language network (Broca\'s and Wernicke\'s areas) as the most relevant with regard to a possible functional signal improvement. In addition, these areas provide an important dichotomy concerning their susceptibility to artifacts: Wernicke lies in the posterior superior temporal gyrus, a relatively magnetically homogeneous region while Broca, in the inferior frontal cortex, is subject to much higher susceptibility-related field gradients. Broca and Wernicke activation clusters were defined for every patient by a clinical fMRI expert (RB) on the basis of the individual SPM t-maps and the existing functional medical reports. This was done for both field strengths. Afterwards the voxels with the highest t-values in each Broca and Wernicke cluster were identified. These peak voxels served as the center for patient-specific spherical regions of interest (ROI), which had a radius of 5 mm. To avoid the inclusion of non-brain areas (e.g. scalp, skull) ROIs were defined on the skull-stripped mean EPI volume (BET2 with a subject specific fractional intensity threshold, [@bb0080]). Spherical ROIs were cropped at the brain border if necessary. Further analysis was limited to these ROIs.

### Quantification of functional activation {#s0070}

Quantification was based on the individual suprathreshold ROI voxels as separately defined for the 3 T and 7 T experiments (whole brain analysis, p \< = 0.05, FWE corrected). To assess effects related to the two field strengths, we compared six measures relevant to functional activation ([@bb0040]): (1) voxel count (number of supra-threshold voxels), (2) mean t-value, (3) peak SPM t-value, (4) percentage signal change, (5) contrast to noise ratio (CNR) ([@bb0060]) and (6) peak CNR.

#### Measures: (1) voxel count, (2) mean t-value and (3) peak t-value {#s0075}

For each patient, all voxels included in the ROI were analyzed for the 3 T and 7 T experiments separately. The voxel count (the number of voxels in the ROI), the mean t-value of all ROI voxels and the highest t-value of all ROI voxels were determined.

#### Measure (4): percentage signal change {#s0080}

Percentage signal change, ΔS/SOFF, was calculated according to the definition of [@bb0140]. In brief, ΔS = (SON − SOFF), where SON is the mean absolute signal of all time points within "ON" phases and SOFF is the mean of all time points within "OFF" phases (arithmetic mean, voxel-wise calculation). For the definition of ON and OFF phases the underlying block design of the paradigm was shifted by 5 s to accord with the delayed BOLD response. This calculation was performed for all voxels within the ROI separately for every run of each patient followed by arithmetic averaging to achieve one representative value per patient and field strength.

#### Measures: (5) contrast to noise ratio (CNR) and (6) peak contrast to noise ratio {#s0085}

CNR was calculated from ΔSCNR/σt-noise, as defined in [@bb0060]. Essentially, the contrast ΔSCNR is the averaged voxel-wise signal change in the temporally smoothed original signal: (mean value of all time points within the "ON" phase) − (mean value of all time points within the "OFF" phase). ON/OFF definitions were the same as for the percentage signal change analysis (measure 4, see above). Smoothing was performed using a Savitzky--Golay filter with a polynomial order of 2 and length 5. σt-noise is the non-task-related variability over time --- in this case the standard deviation of the difference between the original and smoothed signals. Again, this calculation was performed for all voxels within the ROI and every run of each patient, followed by arithmetic averaging to achieve one representative value per patient and field strength. The peak CNR for each patient and field strength was determined by analyzing the mean CNR values of all ROI voxels separately for the 3 T and 7 T experiments.

### Quantification of image quality {#s0090}

Since patient motion leads to ghost-like artifacts in accelerated acquisitions ([@bb0115]) and parallel imaging was used at both field strengths (GRAPPA factor 2 ([@bb0065])), we evaluated 2 measures of image quality. The absolute ghost to signal ratio (GSR~A~) was calculated, and magnetic field gradients in Broca\'s and Wernicke\'s areas were assessed in a subgroup of patients. Ghost to signal ratio (GSR~A~) was calculated similar to the approach used in the EU COMAC-BME II project ([@bb0090]). This measure is defined as the relation of the mean ghosting signal S~ghost~ within 2 ghost contained ROIs and the mean signal within a homogenous white matter ROI S~WM~. ROI selection for this purpose was performed on the 3 central slices of the functional EPI dataset. The white matter ROI S~WM~ was located in a central undisturbed white matter area. The 2 ghost ROIs were located anterior and posterior of the brain and comprised possible ghosting artifacts in the phase-encode direction ([Fig. 2](#f0010){ref-type="fig"}).

Using the SPM motion parameters, we also calculated group mean translational and rotational (pitch, roll, yaw) head motion during 3 T and 7 T experiments.

To explore possible differences in image distortions (and potential signal loss) between Broca\'s and Wernicke\'s areas, in a sample of six patients field maps were generated from additional multi-echo gradient echo (MGE) measurements performed at 7 T. This was done as described in [@bb0105] using a freely available MATLAB toolbox (<http://www.mathworks.com/matlabcentral/fileexchange/30853-field-mapping-toolbox>). The Hermitian inner product was used to generate phase difference images. The gradient of field maps in the primary imaging axes was calculated using MATLAB and the length of the gradient vector G~length~ \[rad∙Hz / voxel\] was calculated using the Euclidean norm. Finally, the mean length inside each enlarged (R = 10 mm) version of the spherical Wernicke and Broca regions of interest was determined ([Table 3](#t0015){ref-type="table"}).

### Statistical evaluation of 3 T--7 T differences {#s0095}

After testing for normally distributed data, paired t-tests comparing 3 T and 7 T values were calculated over all patients for voxel count, mean t-value, peak t-value, percentage signal change, CNR, peak CNR and SNR.

Results {#s0015}
=======

The clinical reports demonstrated left hemispheric Broca and Wernicke activations with all patients and mostly a left hemispheric dominance. The clinical reports had been generated from the same data, however using the local risk map technique which includes an evaluation of the reliability of activations achieved with repetitive runs and based on different reference functions ([@bb0030; @bb0035]). Statistical results of the ROI analysis of the present study are summarized in [Table 2](#t0010){ref-type="table"} and [Figs. 3, 4](#f0015 f0020){ref-type="fig"}. Due to investigating non-normalized data, no MNI coordinates for slices/brain activations can be given.

 {#s0110}

### Quantification of functional activation {#s0100}

Within Wernicke\'s area, 5 of 6 measures showed a significant improvement of functional sensitivity for the 7 T measurements. In Broca\'s area, in contrast, no measure demonstrated a significant benefit for the 7 T system. In detail, the measures (2) mean t-value, (3) peak t-value, (4) percentage signal change, (5) contrast to noise ratio and (6) peak contrast to noise ratio show significant 7 T benefits in Wernicke\'s area. Measure (1) voxel count did not show a 7 T benefit, neither for Wernicke\'s area nor for Broca\'s area ([Table 2](#t0010){ref-type="table"}).

### Quantification of image quality {#s0105}

Analysis of ghosting artifacts showed a significantly increased GSR~A~ level in 7 T, particular in Nyquist ghosting and parallel imaging reconstruction errors ([Table 2](#t0010){ref-type="table"}). This means that ghosting artifacts are larger with 7 T measurements. Head motion, which also worsens parallel imaging reconstruction errors, was also significantly larger for the 7 T measurements (except pitch direction, [Table 2](#t0010){ref-type="table"}). Evaluation of 7 T image distortions in Broca\'s and Wernicke\'s areas showed that the mean magnetic field gradient in Broca\'s area was higher than that in Wernicke\'s area for all patients, and this difference was statistically significant (Wilcoxon Signed Ranks Test, [Table 3](#t0015){ref-type="table"}). This indicates that missing functional signal benefits for 7 T in Broca\'s area are most likely due to larger magnetic field inhomogeneities there.

Discussion {#s0020}
==========

This study provides the first data quantifying possible UHF fMRI benefits for the investigation of cognitive networks. As a prominent and clinically-relevant cognitive function, we selected the language network for this investigation. The results show that different network components may benefit differently from UHF systems, despite representing the same level of functional significance (Broca\'s and Wernicke\'s areas both represent essential language cortex). We made significant efforts to minimize all effects not related to B0 field strength differences by two approaches. First, variations in experimental parameters (including voxel size) and MR hardware (manufacturers, coil types) were kept as minimal as possible. Second, possible effects of post-processing -- which may influence fMRI results, particularly for pathological brains -- were minimized: all signal parameters were calculated from original (non-transformed) functional EPI images using identical methodology for 3 T and 7 T.

The dissociation of UHF benefits within the language network was considerable in our population (Broca 0/6--Wernicke 5/6 parameters significant). This indicates that a functional UHF benefit is readily achievable for superior temporal and central areas (motor system, [@bb0040]), however improvements were not evident for inferior frontal areas. The most likely explanation for this is the increased susceptibility-related field gradients in inferior frontal brain areas causing increased artifacts at UHF. This is evidenced by the original functional EPI images ([Fig. 3](#f0015){ref-type="fig"}) and the field map results. Field maps show significantly larger gradients in B0 in Broca\'s compared to Wernicke\'s area, causing increased signal dropouts. As gradients in B0 scale approximately linearly with field strength, signal loss in Broca\'s area is considerably lower with our 3 T data. As with our previous study, ghosting and head motion artifacts were also larger at 7 T compared to 3 T, although these should not differentially affect Broca\'s and Wernicke\'s areas. The same is true for possible environmental factors like psychological effects due to varying comfort (the 3 T system has a shorter bore, and is more brightly lit). Such environmental factors are unlikely to confound signal changes such that UHF sensitivity is only reduced for Broca\'s area.

Concerning limitations of the study, it is important to realize that secure conclusions can only be drawn for the particular population and the specific cognitive network studied. Our population represents a typical one for cognitive clinical fMRI applications with varying locations and extensions of pathologies, only partially and not systematically affecting Broca and Wernicke cortexes. It cannot be excluded that our results are influenced by these pathologies (e.g. tumor vessels and inhomogeneities can lead to false positive results), and would be different with healthy populations. On the other hand, the general anatomical conditions for frontal and superior temporal brain areas are also present in healthy brains (particularly the brain--air relationship in inferior frontal cortex). Inferior frontal regions are generally more prone to susceptibility-related signal loss than superior temporal brain areas --- and the problem of signal loss scales with field strength. A casual subanalysis which we performed on a patient subset lacking an inferior frontal pathology supports this view since it showed the same functional sensitivity lack for Broca\'s compared to Wernicke\'s area.

Another issue relevant for generalizing conclusions from our current data concerns the possibility that extended 7 T specific optimizations of the experimental setup and the MR sequences might increase the chances to generate a functional UHF benefit for Broca\'s area as well. Such procedures could counteract the known increase of imaging problems at very high field (e.g. geometric distortions ([@bb0105]), signal dropouts and an increase in parallel imaging artifacts ([@bb0040; @bb0115])). For example, 3D-EPI acquisition techniques ([@bb0095; @bb0145]) provide a better image quality and less artifacts in critical brain regions at 7 T. The field strength dependent increase of BOLD noise at 7 T compared to 3 T can be reduced by a reduction of slice thickness and voxel size at 7 T, leading to artifact reduction in critical brain regions and nevertheless a sufficient signal gain ([@bb0135]). However, we did not choose this approach since it would inevitably increase the methodological differences between the 3 T and 7 T experiments which we attempted to minimize. For this initial cognitive network investigation studying potential UHF benefits, we wanted to apply a field strength comparison with widely used and clinically implemented standard technologies. This should be most practically relevant and informative with respect to pure field strength effects, however does not allow conclusions about maximum 7 T benefits achievable under specific experimental conditions. Note, that smaller voxel sizes are typically not necessary for the evaluation of cognitive network activations and would bias a pure field strength comparison against 3 T. Overall, our approach allows inferences as to where UHF benefits may be expected without special application conditions (such as custom hardware, non-standard sequences, or preselected participants).

In summary, our data indicate that the functional UHF benefits reported by most prior UHF studies do not immediately and unambiguously translate to cognitive networks. For a comprehensive picture and particularly for clinical applications it will be important to extend the current database about the network types and network nodes for which UHF gains occur. This will require future studies on other cognitive networks and also on the ameliorating effects of technical improvements. Promising candidates for improvement include system specific sequence optimizations, multiband imaging ([@bb0110]), dynamic distortion correction techniques ([@bb0150]) and sequences which are less prone to reconstruction errors in the presence of motion and are inherently virtually free of Nyquist ghosting ([@bb9000]). From the present data our conclusion is that functional UHF benefits are evident, however these depend crucially on the brain region investigated and the ability to control local artifacts.
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![ROI generation in a representative patient (P 16) at 7 T. A: SPM-t-map (p \< 0.05, FWE corrected) with Broca (blue circle) and Wernicke activations (green circle). B: Peak voxel (yellow) served as the center for a patient specific spherical region of interest (ROI) with a radius of 5 mm for Broca \'s area (blue) and Wernicke\'s area (green). C: Suprathreshold voxels within the ROIs.](gr1){#f0005}

![EPI images for visualizing of ghosting artifacts (P7, 7 T data). Green: ROIs for detection of ghosting signals, blue: central reference ROI. The relation between the mean absolute signals within the ghosting ROIs and the reference ROIs was calculated.](gr2){#f0010}

![Functional MRI data (FWE \< 0.05, left hemisphere on the right) of P7 and P16 comparing corresponding 3 T and 7 T functional activations. Note extended postoperative artifacts with P7. In contrast to the 7 T benefit for Wernicke\'s area, there is a clear 7 T signal loss in Broca\'s area.](gr3){#f0015}

![Broca/Wernicke behavior of the functional activation measures (compare [Table 2](#t0010){ref-type="table"}). Only Wernicke\'s area showed a significant (marked by an asterisk '\*') ultra highfield benefit. Error bars indicate standard deviation.](gr4){#f0020}

###### 

Demographic and clinical details.

  Patient   Sex   Age   Localization of pathology         Pathological diagnosis at the time of fMRI
  --------- ----- ----- --------------------------------- ---------------------------------------------------------------------------------------
  P1        F     20    Right frontal                     Low grade glioma
  P2        M     67    Left parietal postcentral         Tumor of unknown origin
  P3        M     34    Left fronto-temporal              Recurrent astrocytoma grade II
  P4        F     14    Left temporal                     Temporal lobe epilepsy
  P5        M     21    Right central                     Low grade glioma central
  P6        F     39    Left temporo-parietal             Astrocytoma
  P7        F     18    Left temporal                     Temporal lobe epilepsy, hippocampus atrophy and sclerosis, previous partial resection
  P8        M     12    Left temporal                     Temporal lobe epilepsy
  P9        F     38    Left frontal                      Low grade glioma
  P10       F     47    Left frontal                      Recurrent glioma
  P11       M     64    Left opercular                    Grade II astrocytoma
  P12       F     13    Left parieto-temporo-occipital    Epilepsy, focal cortical dysplasia
  P13       M     69    Left temporo-parietal             Tumor of unknown origin
  P14       M     38    Left frontal                      Recurrent low grade glioma
  P15       F     8     Bilateral frontal and occipital   Frontal lobe epilepsy, bilateral dysplasia
  P16       M     27    Left temporo-parietal             Tumor of unknown origin
  P17       M     38    Left temporal                     Cavernoma
  P18       M     37    Left fronto-temporal              Low grade glioma
  P19       M     17    Left temporo-occipital            Epilepsy, tumor of unknown origin
  P20       F     12    Right occipital                   Epilepsy, cystic lesion
  P21       M     23    Left frontal                      Low grade glioma
  P22       F     54    Left precentral                   Tumor of unknown origin
  P23       M     32    Left insular                      Tumor of unknown origin
  P24       M     35    Left frontal                      Recurrent tumor of unknown origin
  P25       F     35    Left insular                      Grade II astrocytoma
  P26       M     38    Left frontal                      Low grade astrocytoma

###### 

Summary of the 3 T and 7 T results.

  Measure                                      3 T value (SD)        7 T value (SD)        p-Value
  -------------------------------------------- --------------------- --------------------- ---------
  *Broca*                                                                                  
  Voxel count                                  27.6 (13.3)           24.8 (15.5)           n.s.
  Mean t-value                                 7.2 (1.3)             7.7 (2.7)             n.s.
  Peak t-value                                 9.4 (2.5)             10.2 (3.8)            n.s.
  Percentage signal change (%, mean of fROI)   1.0 (0.8)             1.6 (1.7)             n.s.
  Contrast to noise ratio (CNR)                1.5 (0.7)             1.6 (0.7)             n.s.
  Peak CNR                                     2.2 (0.9)             2.2 (1.1)             n.s.
                                                                                           
  *Wernicke*                                                                               
  Voxel count                                  30.2 (14.7)           32.6 (15.0)           n.s.
  Mean t-value                                 8.3 (2.7)             11.1 (4.4)            0.004
  Peak t-value                                 11.5 (4.7)            16.3 (6.6)            0.0007
  Percentage signal change (%, mean of fROI)   1.1 (0.5)             1.5 (0.7)             0.005
  Contrast to noise ratio (CNR)                1.9 (0.7)             2.3 (0.9)             0.006
  Peak CNR                                     2.8 (1.3)             3.9 (1.7)             0.0002
                                                                                           
  *Motion indication*                                                                      
  Translation (mm)                             0.09 (0.05)           0.17 (0.08)           0.00004
  Rotation (rad)                                                                           
  Pitch                                        8.9E− 4 (9.1E − 4)    1.1E − 3 (7.0E − 4)   n.s.
  Roll                                         3.7E − 4 (1.7E − 4)   5.3E − 4 (3.1E − 4)   0.004
  Yaw                                          2.9E − 4 (1.3E − 4)   4.0E − 4 (2.6E − 4)   0.017
                                                                                           
  *Static image quality*                                                                   
  GSR~A~                                       5.3E − 2 (1.2E − 2)   1.1E − 1 (6.9E − 2)   0.00013

###### 

Field map results.

  Patient               G~length~ \[rad∙Hz / voxel\]   Difference \[rad∙Hz / voxel\]   
  --------------------- ------------------------------ ------------------------------- --------
  P1                    61.458                         28.087                          33.371
  P5                    123.951                        71.466                          52.485
  P13                   128.792                        64.285                          64.507
  P17                   30.892                         8.854                           22.038
  P20                   59.176                         30.096                          29.08
  P22                   82.068                         28.638                          53.43
                                                                                       
  *Statistical tests*                                                                  
  Wilcoxon              0.028                                                          
  Sign Test             0.031                                                          
